For example, Lu’s group demonstrated the delivery of an anti-inflammatory and antioxidant agent named the basic fibroblast growth factor via an RBC-membrane-coated PLGA NP system (bFGF-RBC/NPs), which showed promise in treating myocardial injury in a murine sepsis model established by CLP (Li et al., 2022). The gene discussed is FGF2; the disease is Sepsis.